Are you searching for effective treatment options for depression? If so, NY Ketamine Infusions is here to provide vital information about an exciting new treatment option on the horizon: Spravato®. This FDA-approved esketamine nasal spray offers a new FDA-approved option for those struggling with treatment-resistant depression (TRD) and major depressive disorder (MDD). With Spravato® launching soon, let’s dive into what this treatment is all about and how it may fit into your journey toward mental wellness.
What Is Spravato®?
Spravato® is an esketamine nasal spray that has received approval from the FDA for two indications: (1) Treatment-Resistant Depression (TRD) in adults, either alone or in combination with an oral antidepressant, and (2) depressive symptoms in adults with Major Depressive Disorder (MDD) with acute suicidal ideation or behavior, in combination with an oral antidepressant.
How Does Spravato® Work?
You might be wondering, “How does Spravato® work?” Unlike traditional antidepressants that primarily target serotonin or norepinephrine systems in the brain, Spravato® focuses on the glutamate system. Glutamate is a neurotransmitter that plays an essential role in synaptic plasticity and neural communication. By modulating these systems, Spravato® can potentially help restore the brain’s natural pathways, creating a quicker and more effective response in alleviating depressive symptoms. This novel mechanism makes it an excellent option for those who haven’t benefited from standard treatments.
Who Is Spravato® For?
Spravato® is primarily intended for adults diagnosed with treatment-resistant depression or major depressive disorder. If you find that traditional antidepressants haven’t provided sufficient relief, this therapy could be an option worth exploring. However, it’s crucial to consult with a healthcare professional to assess your unique situation and confirm whether Spravato® is appropriate for your specific needs.
Why Choose Spravato® at NY Ketamine Infusions?
At NY Ketamine Infusions, we have over 12 years of experience in providing exceptional care and have treated more than 8,000 patients. Our clinic, led by Dr. Mazhraruddin, is dedicated to helping individuals find relief from depression through innovative treatments like IV ketamine infusions and now, Spravato®.
It’s important to note that Spravato® is not a replacement for IV ketamine therapy but rather a complementary option. This means that if you’re currently benefiting from ketamine infusions, you may also consider incorporating Spravato® into your treatment plan for enhanced results. Your well-being is our priority, and we aim to provide comprehensive care tailored to your unique mental health needs.
When Spravato® becomes available, it will be administered at our certified clinic under rigorous REMS (Risk Evaluation and Mitigation Strategy) guidelines. This ensures that each session is conducted with medical supervision. As required by the FDA’s Risk Evaluation and Mitigation Strategy (REMS) program, patients must remain under observation for at least two hours after administration, and Spravato® is not permitted for home use. Spravato® is not a replacement for IV ketamine therapy. Both are evidence-based treatment options that may be appropriate for different patients, depending on individual needs and medical history.
Important Safety Information:
Spravato® may cause sedation, dissociation, and respiratory depression, and it carries the potential for abuse and misuse. Patients should be closely monitored for suicidal thoughts and behaviors. Blood pressure will be monitored during and after treatment, and this medication is not recommended during pregnancy.
At NY Ketamine Infusions, we have treated more than 8,000 patients since opening in 2012. Spravato® is offered as an additional treatment option—complementing our longstanding IV ketamine program. Both modalities are supported by evidence and may suit different patient needs. Your care team will work with you to determine which path best aligns with your medical history and treatment goals.
Final Thoughts
In conclusion, Spravato® represents a significant advancement in the treatment of treatment-resistant depression and major depressive disorder. By targeting the glutamate system, this esketamine nasal spray offers a new avenue for individuals seeking rapid relief from their depressive symptoms. At NY Ketamine Infusions, we’re committed to providing you with personalized care and innovative solutions as you navigate your mental health journey.
If you’re ready to explore whether Spravato® or IV ketamine infusions are right for you, don’t hesitate to reach out. Get in touch with us today to learn more about our offerings and how we can help you on your path to healing.
This content is for informational purposes only and is not a substitute for professional medical advice. SPRAVATO® is only available through a certified treatment center under the FDA REMS program, with on-site monitoring and no home use permitted. Please see the Full Prescribing Information for additional safety details.